"Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced mri mimicking hypervascular tumor

American Journal of Roentgenology

Volumn 193, Issue 6, 2009, Pages

  Doo, Kyung Won ^a   Lee, Chang Hee ^a   Choi, Jae Woong ^a   Lee, Jongmee ^a   Kim, Kyeong Ah ^a   Park, Cheol Min ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Abdominal imaging; Gadoxetic acid; Hemangioma; Liver; MRI

Indexed keywords

GADOBUTROL; GADOXETIC ACID;

ADULT; AGED; ARTICLE; CASE REPORT; CONTRAST ENHANCEMENT; DRUG DELIVERY SYSTEM; HUMAN; LIVER BLOOD FLOW; LIVER HEMANGIOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; VASCULAR TUMOR;

AGED; BIOPSY; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; GADOLINIUM DTPA; HEMANGIOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 73449097173     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.08.1732     Document Type: Article

References (15)

1. Jang HJ, Kim TK, Lim HK, et al. Hepatic hemangioma: atypical appearances on CT, MR imaging, and sonography. AJR 2003; 180:135-141
2. Kim KW, Kim TK, Han JK, Kim AY, Lee HJ, Choi BI. Hepatic hemangiomas with arterioportal shunt: findings at two-phase CT. Radiology 2001; 219:707-711
3. Burkholz KJ, Silva AC. AJR teaching file: hypervascular metastasis or hepatic hemangioma? AJR 2008; 190[6 suppl]:S53-S56
4. Huppertz A, Haraida S, Kraus A, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology 2005; 234:468-478
5. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992; 183:59-64
6. Weinmann HJ, Schuhmann-Giampieri G, Schmitt-Willich H, Vogler H, Frenzel T, Gries H. A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn Reson Med 1991; 22:233-237, discussion 242
7. Giovanoli O, Heim M, Terracciano L, Bongartz G, Ledermann HP. MRI of hepatic adenomatosis: initial observations with gadoxetic acid contrast agent in three patients. AJR 2008; 190:1340; [web]W290-W293
8. Reimer P, Rummeny EJ, Daldrup HE, et al. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol 1997; 7:275-280
9. Brody JM, Schafer L, Tung GA, Breuer J, Shamsi K. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid. J Magn Reson Imaging 2005; 21:391-397
10. Semelka RC, Brown ED, Ascher SM, et al. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 1994; 192:401-406
11. Yamashita Y, Ogata I, Urata J, Takahashi M. Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings. Radiology 1997; 203:121-125
12. Huppertz A, Balzer T, Blakeborough A, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 2004; 230:266-275
13. Vogl TJ, Kummel S, Hammerstingl R, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996; 200:59-67
14. Hammerstingl R, Huppertz A, Breuer J, et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 2008; 18:457-467
15. Halavaara J, Breuer J, Ayuso C, et al. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT-a multicenter trial. J Comput Assist Tomogr 2006; 30:345-354